216 related articles for article (PubMed ID: 6342898)
1. Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.
Aronson JK
Clin Pharmacokinet; 1983; 8(2):155-78. PubMed ID: 6342898
[No Abstract] [Full Text] [Related]
2. [Studies on the pharmacokinetics of meproscillarin (author's transl)].
Belz GG; Belz G
Arzneimittelforschung; 1978; 28(3a):535-9. PubMed ID: 580584
[No Abstract] [Full Text] [Related]
3. Disease-related alterations in cardiac glycoside disposition.
Ochs HR; Greenblatt DJ; Bodem G; Dengler HJ
Clin Pharmacokinet; 1982; 7(5):434-51. PubMed ID: 6754209
[No Abstract] [Full Text] [Related]
4. [Introduction to clinical pharmacodynamics and pharmacokinetics of cardiac glycosides].
Kudrin AN; Namakanov BA; Davydova ON
Sov Med; 1981; (11):70-4. PubMed ID: 7038899
[No Abstract] [Full Text] [Related]
5. [Renal elimination kinetics of various several cardiac glycosides].
Kramer P; Scheler F
Dtsch Med Wochenschr; 1972 Oct; 97(40):1485-90. PubMed ID: 5071762
[No Abstract] [Full Text] [Related]
6. Drug pharmacokinetics in thyroid dysfunction.
Rodighiero V
Minerva Endocrinol; 1985; 10(2):97-113. PubMed ID: 2415808
[No Abstract] [Full Text] [Related]
7. [Pharmacokinetics of cardiac glycosides and clinical consequences].
Rietbrock N; Kuhlmann J; Vöhringer HF
Fortschr Med; 1977 Apr; 95(14):909-15, 951-4. PubMed ID: 856698
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of valproic acid.
Gugler R; von Unruh GE
Clin Pharmacokinet; 1980; 5(1):67-83. PubMed ID: 6767575
[No Abstract] [Full Text] [Related]
9. [On the pharmacokinetics of peruvoside. II. Comparative studies with H3-ouabain and H3-digitoxin in guinea pigs].
Garbe A; Nowak H
Arzneimittelforschung; 1968 Dec; 18(12):1597-601. PubMed ID: 5756472
[No Abstract] [Full Text] [Related]
10. [A study of the kinetics of cardiac glycosides in the human organism].
van Zwieten PA
Ned Tijdschr Geneeskd; 1971 Jan; 115(4):157-62. PubMed ID: 4926491
[No Abstract] [Full Text] [Related]
11. Proceedings: Influence of spironolactone pretreatment on pharmakokinetics and metabolism of digitoxin in the rat.
Vöhringer HF; Stolpmann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R102. PubMed ID: 4276666
[No Abstract] [Full Text] [Related]
12. [Serum level and excretion of H3 labeled cardiac glycosides under normal and pathological conditions].
Lahrtz H; van Zwieten PA
Radiobiol Radiother (Berl); 1969; 10(6):841. PubMed ID: 5379979
[No Abstract] [Full Text] [Related]
13. [Optimization of therapy using cardiac glycosides].
Ziesenhenn K; Behn P
Z Gesamte Inn Med; 1978 Nov; 33(22):830-3. PubMed ID: 746673
[TBL] [Abstract][Full Text] [Related]
14. [The importance of the biliary excretion of drugs in the human].
Siegers CP; Klaassen CD
Dtsch Med Wochenschr; 1983 Oct; 108(41):1564-70. PubMed ID: 6352227
[No Abstract] [Full Text] [Related]
15. Clinical pharmacokinetics.
Atkinson AJ; Kushner W
Annu Rev Pharmacol Toxicol; 1979; 19():105-27. PubMed ID: 378099
[No Abstract] [Full Text] [Related]
16. [Therapeutic equivalence and inequivalence of chemically identical substances using cardiac glycosides for an example (author's transpl)].
Rietbrock N
Arzneimittelforschung; 1976; 26(1A):135-46. PubMed ID: 947193
[TBL] [Abstract][Full Text] [Related]
17. Drug kinetics and artificial kidneys.
Gibson TB; Nelson HA
Clin Pharmacokinet; 1977; 2(6):403-26. PubMed ID: 22417
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological approach to the rational use of cardiotonic heterosides].
Tillement JP; Albengres E
Coeur Med Interne; 1977; 16(2):239-48. PubMed ID: 891123
[No Abstract] [Full Text] [Related]
19. Renal tubular transport of a polar cardiac glycoside, ASI-222, in rats; clearance and micropuncture studies.
Kauker ML; Nash CB; Caldwell RW
J Pharmacol Exp Ther; 1981 Sep; 218(3):686-91. PubMed ID: 7264952
[No Abstract] [Full Text] [Related]
20. [Metabolism and kinetics of -acetyldigoxin].
Ruiz-Torres A; Burmeister H
Klin Wochenschr; 1972 Feb; 50(4):191-5. PubMed ID: 5011551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
